Safety regulations were just one of the many hurdles in the pipeline from idea to therapy.
But to answer your question, that uterus transplantation was (a) an experimental therapy overseen by an IRB to treat a diagnosed medical condition, (b) almost certainly funded by grants acquired by Baylor and not insurance, and (c) the therapy is still in clinical testing and not available to indicated patients today in 2025, 8 years later, unless they are part of a clinical study, which demonstrates how lengthy the process is.
Safety regulations were just one of the many hurdles in the pipeline from idea to therapy.
But to answer your question, that uterus transplantation was (a) an experimental therapy overseen by an IRB to treat a diagnosed medical condition, (b) almost certainly funded by grants acquired by Baylor and not insurance, and (c) the therapy is still in clinical testing and not available to indicated patients today in 2025, 8 years later, unless they are part of a clinical study, which demonstrates how lengthy the process is.